about
Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neuronsStructural Characterization of Three Novel Hydroxamate-Based Zinc Chelating Inhibitors of the Clostridium botulinum Serotype A Neurotoxin Light Chain Metalloprotease Reveals a Compact Binding Site Resulting from 60/70 Loop FlexibilityAlpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosisProconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Transcriptomic basis for an antiserum against Micrurus corallinus (coral snake) venom.Botulinum toxin type-A in the treatment of glabellar lines.Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discoveryInhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2.Reduced aspartate release from rat hippocampal synaptosomes loaded with Clostridial toxin light chain by electroporation: evidence for an exocytotic mechanism.Neurotoxin gene profiling of clostridium botulinum types C and D native to different countries within Europe.Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular JunctionContent of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.Phospholipases and fatty acid signalling in exocytosis.Neurotoxins from Australo-Papuan elapids: a biochemical and pharmacological perspective.Postsynaptic response to stimulation of the Schaffer collaterals with properties similar to those of synaptosomal aspartate release.Electrophysiological Characterization of the Antarease Metalloprotease from Tityus serrulatus Venom.Aspartate release and signalling in the hippocampus.Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells.Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity.Animal models for studying motor axon terminal paralysis and recovery.Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synucleinDouble anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons.Pre- and Post-synaptic Effects of Botulinum Toxin A on Submandibular Glands.Mechanism of arachidonic acid action on syntaxin-Munc18.Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.Snake phospholipase A2 neurotoxins enter neurons, bind specifically to mitochondria, and open their transition pores.Traffic of botulinum toxins A and E in excitatory and inhibitory neurons.One collective case of type A foodborne botulism in Corsica.High-throughput enzyme-linked immunoabsorbant assay (ELISA) electrochemiluminescent detection of botulinum toxins in foods for food safety and defence purposes.Polyclonal neural cell adhesion molecule antibody prolongs the effective duration time of botulinum toxin in decreasing muscle strength.Botulinum neurotoxin formulations: overcoming the confusion.Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms.
P2860
Q27339199-B349087D-30D6-4D33-80B4-6D83F89C3A69Q27667317-BF4F0F81-2F34-48CE-BA63-159E66041776Q28580852-2BE58879-4429-4B2F-BA24-0AA6066CF22AQ30405084-046C4185-B642-47C2-A98E-F7DA0C4B69F5Q30451918-57068CDB-71E4-43EC-B037-E1AC43CDFD71Q33418779-9A9336F9-B19F-453C-A5C6-29941C910779Q34620317-1C04C1EB-EF18-4E1D-BCF8-88C1C85D9383Q34850583-9D17E67D-6D22-4A34-B585-4F8F337E13FDQ35529782-A5116789-E399-4C6F-B4BC-F6B4043900B2Q35661155-58ED7F36-6E2E-4F3C-8B04-6AD55FB90886Q35941093-F2DBB18C-B2A0-47D8-A9AE-142D1416C5AEQ36401493-9EF6D2EF-6F30-47F0-87DB-9C15C3669B5CQ36650003-3DBB5B2E-E54F-453E-AA50-7A0D022D9423Q36856225-FC46F0F4-2156-4566-86B3-B6F8B8417C0CQ37045666-B04BA6FF-4269-405D-A5B8-C3A28EB53DCAQ37366723-79A1801C-A67F-4E2B-BE0D-7D4929E7DB64Q37727904-113351CF-0EA9-430F-AAAD-6CAC9512CBB9Q37800822-2917FE2E-2311-4DAB-B363-ADEC352BB751Q37954286-2566CDFE-B7BD-4D78-9E9D-1E7C70136F88Q38843144-57FA54F0-B680-4BD5-981C-1C6804AA6B02Q39192234-88E3B97B-4594-43B6-92BE-38FCBDB6725BQ39348525-F3C19F3D-7B0C-4001-8961-9B3516452357Q39500669-11A64E84-F29D-4841-9605-219DB2DD3CF4Q40831975-3778890E-8059-4589-9D6E-C1D03E6706B5Q41821252-55678C55-6B6B-4244-A54F-FFE7C824711EQ42644905-78A83736-61FD-4A32-AA1D-24CFC9ED3E63Q42939527-E1FB0E10-ED60-494F-9595-90602E0C775FQ43154680-11153866-86AE-41DD-94B4-9DF12DE69122Q48301665-F349307A-2429-4950-B8E7-00D3087321BDQ50510736-3F7053E8-5D41-4544-ABF1-374DB0992FFEQ51802832-3E7CCE56-C10B-4063-B575-8F766AAB4CE9Q53437992-4E9DFC04-4571-4EE0-9FD2-09054981A4C9Q55260245-6B710FDF-265D-497A-A655-78AD1F93E1E8Q55516083-30EB1929-54D6-48AD-83E0-82CC8D7C2CCC
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Presynaptic enzymatic neurotoxins.
@ast
Presynaptic enzymatic neurotoxins.
@en
Presynaptic enzymatic neurotoxins.
@nl
type
label
Presynaptic enzymatic neurotoxins.
@ast
Presynaptic enzymatic neurotoxins.
@en
Presynaptic enzymatic neurotoxins.
@nl
prefLabel
Presynaptic enzymatic neurotoxins.
@ast
Presynaptic enzymatic neurotoxins.
@en
Presynaptic enzymatic neurotoxins.
@nl
P2093
P2860
P1476
Presynaptic enzymatic neurotoxins
@en
P2093
Cesare Montecucco
Laura Morbiato
Michela Rigoni
Paola Caccin
P2860
P304
P356
10.1111/J.1471-4159.2006.03965.X
P407
P577
2006-06-01T00:00:00Z